seen from China
seen from United States
seen from Malaysia
seen from United States
seen from Malaysia
seen from Malaysia
seen from China
seen from Nepal
seen from Australia
seen from China
seen from Malaysia
seen from Malaysia
seen from China
seen from United States
seen from United Kingdom
seen from Germany
seen from Malaysia
seen from China
seen from Kazakhstan
seen from Germany
A study performed by researchers in Iran concluded that nbUVB vitiligo treatments are more successful when associated with topical immunomodulators (Elidel, Protopic).
“Sixty-eight patients with vitiligo enrolled in this randomized, double-blind, placebo-controlled study. Read more
